Canalicular stenosis secondary to weekly versus every-3-weeks docetaxel in patients with metastatic breast cancerESMAELI, Bita; HORTOBAGYI, Gabriel N; ESTEVA, Francisco J et al.Ophthalmology (Rochester, MN). 2002, Vol 109, Num 6, pp 1188-1191, issn 0161-6420Article

Paclitaxel in the multimodality treatment for inflammatory breast carcinomaCRISTOFANILLI, Massimo; BUZDAR, Aman U; UENO, Naoto et al.Cancer. 2001, Vol 92, Num 7, pp 1775-1782, issn 0008-543XArticle

Estrogen Receptor (ER) mRNA and ER-Related Gene Expression in Breast Cancers That Are 1% to 10% ER-Positive by ImmunohistochemistryIWAMOTO, Takayuki; BOOSER, Daniel; MATSUOKA, Junji et al.Journal of clinical oncology. 2012, Vol 30, Num 7, pp 729-734, issn 0732-183X, 6 p.Article

Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancerHESS, Kenneth R; ANDERSON, Keith; ROUZIER, Roman et al.Journal of clinical oncology. 2006, Vol 24, Num 26, pp 4236-4244, issn 0732-183X, 9 p.Article

Phase II study of weekly docetaxel and trastuzumab for patients with HER-2-overexpressing metastatic breast cancerESTEVA, Francisco J; VALERO, Vicente; SNEIGE, Nour et al.Journal of clinical oncology. 2002, Vol 20, Num 7, pp 1800-1808, issn 0732-183XArticle

Effect of Adjuvant/Neoadjuvant Trastuzumab on Clinical Outcomes in Patients With HER2-Positive Metastatic Breast CancerMURTHY, Rashmi K; VARMA, Ankur; BOOSER, Daniel et al.Cancer. 2014, Vol 120, Num 13, pp 1932-1938, issn 0008-543X, 7 p.Article

Elevated serum P1NP predicts development of bone metastasis and survival in early-stage breast cancerDEAN-COLOMB, Windy; HESS, Kenneth R; HORTOBAGYI, Gabriel N et al.Breast cancer research and treatment. 2013, Vol 137, Num 2, pp 631-636, issn 0167-6806, 6 p.Article

A Phase 1 Study of Weekly Everolimus (RAD001) in Combination With Docetaxel in Patients With Metastatic Breast CancerMOULDER, Stacy; GLADISH, Gregory; RIVERA, Edgardo et al.Cancer. 2012, Vol 118, Num 9, pp 2378-2384, issn 0008-543X, 7 p.Article

Phase II trial of 10-EDAM in the treatment of metastatic breast cancerBEINART, Garth A; GONZALEZ-ANGULO, Ana M; YOUNG, James A et al.Cancer chemotherapy and pharmacology. 2007, Vol 60, Num 1, pp 61-67, issn 0344-5704, 7 p.Article

Gene Pathways Associated With Prognosis and Chemotherapy Sensitivity in Molecular Subtypes of Breast CancerIWAMOTO, Takayuki; BIANCHINI, Giampaolo; HOLMES, Frankie A et al.Journal of the National Cancer Institute. 2011, Vol 103, Num 3, pp 264-272, issn 0027-8874, 9 p.Article

Phase II study of tariquidar, a selective P-glycoprotein inhibitor, in patients with chemotherapy-resistant, advanced breast carcinomaPUSZTAI, Lajos; WAGNER, Peter; ROUZIER, Roman et al.Cancer. 2005, Vol 104, Num 4, pp 682-691, issn 0008-543X, 10 p.Article

Gene Expression profiles obtained from fine-needle aspirations of breast cancer reliably identify routine prognostic markers and reveal large-scale molecular differences between estrogen-negative and estrogen-positive tumorsPUSZTAI, Lajos; AYERS, Mark; ARUN, Banu et al.Clinical cancer research. 2003, Vol 9, Num 7, pp 2406-2415, issn 1078-0432, 10 p.Article

Phase I study of a third-generation selective estrogen receptor modulator, LY353381.HCl, in metastatic breast cancerMÜNSTER, Pamela N; BUZDAR, Aman; NORTON, Larry et al.Journal of clinical oncology. 2001, Vol 19, Num 7, pp 2002-2009, issn 0732-183XArticle

Phase I study of stealth liposomal doxorubicin in combination with gemcitabine in the treatment of patients with metastatic breast cancerRIVERA, Edgardo; VALERO, Vicente; HORTOBAGYI, Gabriel N et al.Journal of clinical oncology. 2001, Vol 19, Num 6, pp 1716-1722, issn 0732-183XArticle

A Phase 2 Study of A Fixed Combination of Uracil and Ftorafur (UFT) and Leucovorin Given Orally in A 3-times-daily Regimen to Treat Patients With Recurrent Metastatic Breast CancerHORTOBAGYI, Gabriel N; HEIM, William; HUTCHINS, Laura et al.Cancer. 2010, Vol 116, Num 6, pp 1440-1445, issn 0008-543X, 6 p.Article

Phase II study of liposomal annamycin in the treatment of doxorubicin-resistant breast cancerBOOSER, Daniel J; ESTEVA, Francisco J; RIVERA, Edgardo et al.Cancer chemotherapy and pharmacology. 2002, Vol 50, Num 1, pp 6-8, issn 0344-5704, 3 p.Article

A Phase I study of docetaxel plus cyclophosphamide in solid tumors followed by a Phase II study as first-line therapy in metastatic breast cancersTRENT, Jonathan C; VALERO, Vicente; CRISTOFANILLI, Massimo et al.Clinical cancer research. 2003, Vol 9, Num 7, pp 2426-2434, issn 1078-0432, 9 p.Article

Phase I-II vinorelbine (Navelbine®) by continuous infusion in patients with metastatic breast cancer : Cumulative toxicities limit dose escalationIBRAHIM, Nuhad K; VALERO, Vicente; BAST, Robert et al.Cancer investigation. 2001, Vol 19, Num 5, pp 459-466, issn 0735-7907Article

A nonreplicating adenoviral vector that contains the wild-type p53 transgene combined with chemotherapy for primary breast cancer : Safety, efficacy, and biologic activity of a novel gene-therapy approachCRISTOFANILLI, Massimo; KRISHNAMURTHY, Savitri; GUERRA, Laura et al.Cancer. 2006, Vol 107, Num 5, pp 935-944, issn 0008-543X, 10 p.Article

Phase I study of liposomal annamycinBOOSER, Daniel J; PEREZ-SOLER, Roman; COSSUM, Paul et al.Cancer chemotherapy and pharmacology. 2000, Vol 46, Num 5, pp 427-432, issn 0344-5704Article

Genomic Index of Sensitivity to Endocrine Therapy for Breast CancerSYMMANS, W. Fraser; HATZIS, Christos; DELALOGE, Suzette et al.Journal of clinical oncology. 2010, Vol 28, Num 27, pp 4111-4119, issn 0732-183X, 9 p.Article

Phase I/II Study of G3139 (Bcl-2 Antisense Oligonucleotide) in Combination with Doxorubicin and Docetaxel in Breast CancerMOULDER, Stacy L; FRASER SYMMANS, W; ZWIEBEL, James et al.Clinical cancer research (Print). 2008, Vol 14, Num 23, pp 7909-7916, issn 1078-0432, 8 p.Article

A detailed evaluation of cardiac toxicity: A Phase II study of doxorubicin and one- or three-hour-infusion paclitaxel in patients with metastatic breast cancerGIORDANO, Sharon H; BOOSER, Daniel J; EWER, Michael et al.Clinical cancer research. 2002, Vol 8, Num 11, pp 3360-3368, issn 1078-0432, 9 p.Article

Long-term results of combined-modality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastases : The University of Texas M.D. Anderson Cancer Center ExperienceBRITO, Rogelio A; VALERO, Vicente; ASMAR, Lina et al.Journal of clinical oncology. 2001, Vol 19, Num 3, pp 628-633, issn 0732-183XConference Paper

Rapid induction of complete donor chimerism by the use of a reduced-intensity conditioning regimen composed of fludarabine and melphalan in allogeneic stem cell transplantation for metastatic solid tumorsUENO, Naoto T; YEE CHUNG CHENG; BOOSER, Daniel J et al.Blood. 2003, Vol 102, Num 10, pp 3829-3836, issn 0006-4971, 8 p.Article